Home » Topics » Regulatory

Regulatory
RSS

First approval for Zeneca's Seroquel

Sep. 3, 1997

Ranitidine shows no benefit in psoriasis

Sep. 2, 1997

Migraine prophylaxis with bisoprolol

Sep. 1, 1997

Famotidine for schizophrenia

Sep. 1, 1997

FDA clears new formulation of Imitrex

Sep. 1, 1997

First approval for irbesartan

Sep. 1, 1997

New indication approved for Asacol

Aug. 28, 1997

Tasmar approved in EU for Parkinson's disease

Aug. 28, 1997

Malignant melanoma indication approved for Intron A in U.K.

Aug. 27, 1997

Actiq scheduled for FDA advisory committee review

Aug. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...